Navigation Links
St. Jude Medical to Expand Puerto Rico Operations
Date:9/19/2007

With purchase of Arecibo plant, St. Jude Medical will add up to 1,200 new jobs within 36 months of initiating operations in its second facility in

Puerto Rico

ARECIBO, Puerto Rico, Sept. 19 /PRNewswire-FirstCall/ -- St. Jude Medical, Inc. (NYSE: STJ) today announced plans to expand its operations in Puerto Rico. St. Jude Medical recently purchased a facility in Arecibo's Santana Industrial Park, which will allow the company to increase its Puerto Rico operations by 30 percent and create up to 1,200 new jobs within the next three years.

The facility is expected to begin operating by mid-year 2008. Initially, St. Jude Medical in Arecibo will produce cardiac rhythm management devices, including pacemakers and pacing leads, which are currently produced at the company's Caguas plant. In addition, St. Jude Medical plans to begin manufacturing implantable cardioverter defibrillators (ICDs) and their corresponding high voltage leads at the Arecibo site at a later date.

The Caguas site will continue to manufacture mechanical heart valves and Angio-Seal(TM) vascular closure devices, and also is expected to add new product lines in the future.

"St. Jude Medical's success in Puerto Rico over the past 20 years has been the result of our local team's commitment to upholding the highest standards for quality and manufacturing excellence," said Daniel J. Starks, St. Jude Medical chairman, president and chief executive officer. "Quality is our top priority because our devices are life-saving for many thousands of patients around the world."

St. Jude Medical began operations in Puerto Rico with 25 employees at its current Caguas facility in 1987. The original 23,000 square-
'/>"/>

SOURCE St. Jude Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...t Software agrees to migrate their Microsoft Dynam...ts) to Synergy Business Solutions to maintain qual...A (PRWEB) December 1, 2009 -- Synergy Business Sol...ft Dynamics SL practice of Congruent Software, a B... was necessary due to a change in Congruent Softwa...
(Date:12/1/2009)...c. 1 Aethlon Medical, In... it will present at the LD MICRO Conference on Thu...Luxe Hotel in Los Angeles. Aethlon Medical,s Chair...ate overview and will provide an update on the com... Hemopurifier®, a first-in-class artificial a...
(Date:12/1/2009)...H VANCOUVER, British Columbia, Dec. 1 /PRNewswire-... subsidiary of The Dow Chemical Company (NYSE: D...ed the signing of a research and commercial licens...oSciences with access to Agrisoma,s proprietary En...ve basis in major food crops, and on a non-exclusi...
(Date:12/1/2009)... Medizone International,...hat in tests involving its proprietary AsepticSure...ontamination barriers, this time with two very dif...ile and Bacillis subtilis. These results clearly e...oricidal technology. "The implications of a 6.7 lo...
Breaking Biology Technology:Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2
... DC A new analysis by the Project on Emerging Nan...s are investing nearly twice as much as the U.S. i...tial risks of nanotechnology. The analysis also hi...al governments nanotechnology risk-research invest...nt of nanotechnology risk-relevant projects identi...
... April 21 Boston Scientific,Corporation (NYSE: B...st,quarter ended March 31, 2008, as well as guidan...the second quarter of 2008., First quarter highl...nd adjusted EPS of $0.24 -- Improved earnings thr...ntained leading position in the worldwide drug-elu...
...erence Call Today at 5:00 p.m., CAMBRIDGE, Mass.,...nounced today that the FDA has informed the,compan...fa) produced at the,160L bioreactor scale and Myoz...ed as two different products because of difference... Currently, Genzyme has U.S.,approval to sell Myoz...
Other Biology Technology:Europe spends nearly twice as much as US on nanotech risk research 2Boston Scientific Announces Results for First Quarter Ended March 31, 2008 2Boston Scientific Announces Results for First Quarter Ended March 31, 2008 3Boston Scientific Announces Results for First Quarter Ended March 31, 2008 4Boston Scientific Announces Results for First Quarter Ended March 31, 2008 5Boston Scientific Announces Results for First Quarter Ended March 31, 2008 6Boston Scientific Announces Results for First Quarter Ended March 31, 2008 7Boston Scientific Announces Results for First Quarter Ended March 31, 2008 8Boston Scientific Announces Results for First Quarter Ended March 31, 2008 9Boston Scientific Announces Results for First Quarter Ended March 31, 2008 10Boston Scientific Announces Results for First Quarter Ended March 31, 2008 11Boston Scientific Announces Results for First Quarter Ended March 31, 2008 12Boston Scientific Announces Results for First Quarter Ended March 31, 2008 13Boston Scientific Announces Results for First Quarter Ended March 31, 2008 14Boston Scientific Announces Results for First Quarter Ended March 31, 2008 15Boston Scientific Announces Results for First Quarter Ended March 31, 2008 16Boston Scientific Announces Results for First Quarter Ended March 31, 2008 17Boston Scientific Announces Results for First Quarter Ended March 31, 2008 18Genzyme Provides Update on Myozyme(R) Manufacturing 2Genzyme Provides Update on Myozyme(R) Manufacturing 3Genzyme Provides Update on Myozyme(R) Manufacturing 4Genzyme Provides Update on Myozyme(R) Manufacturing 5
(Date:11/30/2009)...r thought the stress of seeing your extended famil...: a new research report in the December 2009 print...p://www.jleukbio.org ) shows that you might be rig...udy might lead to entirely new treatments that hel...and eczema under control. That,s because researche...
(Date:11/30/2009)... a colorless and odorless radioactive gas that is ...m is a product of uranium decay and is found in tr...and groundwater as well as building materials, pla...ntration is expressed as the amount of radiation t...ts in a liter of air; thus the units are picocurie...
(Date:11/26/2009)... have at last worked out a way of using recordings...d populations. This is the first time sound record...into accurate estimates of bird species, populatio...tish Ecological Society,s Journal of Applied Ecol...d to a major advance in our ability to monitor wha...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Health Physics Society recommends considering action for indoor radon below current guidelines 2Ecologists sound out new solution for monitoring cryptic species 2GfK Asia Reports 3A Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 61405 1GfK Asia Reports 3A Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 61405 2GfK Asia Reports 3A Malaysian Contact Lens Market Sees Strong Recovery in Second Half of 2009 61405 3Frost 26amp 3B Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market 14842 1Frost 26amp 3B Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market 14842 2New View Of Reality 28In Printed Book Form 29 That Combines Einstein And Quantum Mechanics And Fills The World With Miracles 61401 1New View Of Reality 28In Printed Book Form 29 That Combines Einstein And Quantum Mechanics And Fills The World With Miracles 61401 2New View Of Reality 28In Printed Book Form 29 That Combines Einstein And Quantum Mechanics And Fills The World With Miracles 61401 3
...ational Academy of Sciences, Sackler Colloquium se...ks. These networks represent the genomic program ... and cell types. The meeting will focus on four a...y embryonic development; gene networks later devel...x multigenic systems; and understanding the genera...
...s release is also available in French . Resear...Gill University have identified the neurological b...g post-concussion symptoms. The study, published i...ry, has important clinical implications for the tr...l concussion. , Depression is one of a number of...
...T CREEK, CA--A preliminary assembly and annotation... available by the U.S. Department of Energy Joint ...fic community to enable bioenergy research. , The...ctor, during his keynote remarks Jan. 15 at the Pl...CA. The preliminary data can be accessed at http:...
Other Biology News:MNI researchers locate neurological basis of depression following sports concussion 2DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts 2DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts 3
Chaps Cell Extract Buffer (10X) from Cell Signaling Technology
Mouse Anti-TGE Virus peplomer Monoclonal Antibody, Unconjugated, Clone 1Q17 from Abcam
Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-Lck, phospho (Tyr192) Polyclonal Antibody, Unconjugated from Abcam
Biology Products: